Akari Therapeutics PLC(AKTX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

AKTX Akari Therapeutics PLC

Pre-Mkt 07-27 08:04:02 EDT

8.70

-0.60

-6.45%

盘前8.79

+0.09+1.03%

04:06 EDT

High9.55	Low8.42	Vol28.10K
Open8.88	D1 Closing9.30	Amplitude12.16%
Mkt Cap15.23M	Tradable Cap6.04M	Total Shares1.75M
T/O251.79K	T/O Rate4.05%	Tradable Shares694.50K
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"AKTX","market":"US","secType":"STK","nameCN":"Akari Therapeutics PLC","latestPrice":8.7,"timestamp":1784923200000,"preClose":9.3,"halted":0,"volume":28095,"hourTrading":{"tag":"盘前","latestPrice":8.79,"preClose":8.7,"latestTime":"04:06 EDT","volume":10,"amount":87.27000000000001,"timestamp":1785139589255,"change":0.09,"changeRate":0.010345,"amplitude":0.008046},"delay":0,"changeRate":-0.06451612903225822,"floatShares":694500,"shares":1750400,"eps":-26.914133,"marketStatus":"Pre-Mkt","change":-0.6,"latestTime":"07-27 08:04:02 EDT","open":8.88,"high":9.5506,"low":8.42,"amount":251789.946645,"amplitude":0.12157,"askPrice":11.21,"askSize":100,"bidPrice":7.32,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-26.914133,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1785159000000},"marketStatusCode":1,"adr":1,"adrRate":2000,"exchange":"NASDAQ","adjPreClose":8.7,"preHourTrading":{"tag":"盘前","latestPrice":8.79,"preClose":8.7,"latestTime":"04:06 EDT","volume":10,"amount":87.27000000000001,"timestamp":1785139589255,"change":0.09,"changeRate":0.010345,"amplitude":0.008046},"postHourTrading":{"tag":"盘后","latestPrice":8.7,"preClose":8.7,"latestTime":"18:22 EDT","volume":27,"amount":231.06,"timestamp":1784931755361,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.6230940405993893,"impliedVol":1.53,"impliedVolPercentile":0.7586},"requestUrl":"/m/hq/s/AKTX/wiki","defaultTab":"wiki","newsList":[{"id":"2653769130","title":"European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2653769130","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653769130?lang=en_us&edition=fundamental","pubTime":"2026-07-22 23:10","pubTimestamp":1784733024,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were tracking higher late Wednesday morning, rising 0.69% to 1,924.81 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by biopharmaceutical company Cellectis  and petroleum refiner Equinor , which climbed 6.8% and 4.9%, respectively. They were followed by semiconductor company Sequans Communications  and brewing company Anheuser-Busch InBev , which advanced 4% and 2.8%, respectively.The decliners from continental Europe were led by internet browser company Opera  and biopharmaceutical company DBV Technologies , which dropped 3.3% and 2.9%, respectively. They were followed by telecommunications company Nokia  and software firm SAP , which lost 2.6% and 2%, respectively.The gainers from the UK were led by biopharmaceutical firm Akari Therapeutics  and insurance firm Prudential , which rose 6.6% and 3.4%, respectively. They were followed by lender HSBC  and telecommunications company operato","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2236285917.USD","TRIB","BK4132","AFG","LFGY","BK4201","BK4521","EQNR","IEUR","BK4532","BK4107","BK4588","BK4020","BK4023","BK4141","HSBC","BK4158","BK4207","LU0310800965.SGD","IE00BMPRXN33.USD","BK4082","BK4117","EPV","PSO","LNOK","LU0052756011.USD","VOD","NOK","BUD","DBVT","SAP","BK4204","LU0976567544.SGD","BK4528","SQNS","LU0496365809.HKD","LU0211326839.USD","LU0128525689.USD","BDRX","OPRA","HSBH","BK4139","IE00BMPRXR70.SGD","CLLS","AKTX","PUK","BUD.AU","LU0211326755.USD","SLN","BK4162"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653768898","title":"Akari Therapeutics Enters Strategic ADC Payload Research Collaboration with Whitehawk Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2653768898","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653768898?lang=en_us&edition=fundamental","pubTime":"2026-07-22 20:40","pubTimestamp":1784724025,"startTime":"0","endTime":"0","summary":"Akari Therapeutics enters strategic ADC payload research collaboration with Whitehawk TherapeuticsAkari Therapeutics entered a strategic research collaboration with Whitehawk Therapeutics to evaluate ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260722:nNDL81G8CN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCDF","BK4588","IE00BN0W2W23.USD","LU2210149790.SGD","LU2210150020.SGD","SG9999014013.SGD","NDAQ","IE00BKPKM429.USD","IE00B3QW5Z07.USD","IE00BN0W2V16.EUR","SG9999014039.USD","AKTX","BK4007","SG9999014021.USD","LU2095319765.USD","IE00BN0W2T93.GBP","BK4585","IE00BGHQF748.EUR","LU0314104364.USD","SG9999014005.SGD","BK4112","BK4139","IE00B64PRP62.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653711942","title":"Akari Therapeutics Enters Preclinical ADC Research Collaboration with Whitehawk Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2653711942","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653711942?lang=en_us&edition=fundamental","pubTime":"2026-07-21 19:06","pubTimestamp":1784632000,"startTime":"0","endTime":"0","summary":"Akari Therapeutics enters preclinical ADC research collaboration with Whitehawk TherapeuticsAkari Therapeutics entered a strategic research collaboration with Whitehawk Therapeutics to run preclinical","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260721:nNDLZ5M5K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014021.USD","AKTX","BK4007","BCDF","BK4585","BK4588","LU2095319765.USD","IE00BN0W2T93.GBP","SG9999014005.SGD","BK4112","IE00BN0W2V16.EUR","IE00B3QW5Z07.USD","IE00BN0W2W23.USD","SG9999014039.USD","LU0314104364.USD","LU2210150020.SGD","IE00B64PRP62.GBP","SG9999014013.SGD","NDAQ","BK4139","IE00BGHQF748.EUR","IE00BKPKM429.USD","LU2210149790.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653719702","title":"Akari Therapeutics - Collaboration to Commence Immediately with Interim Data Updates Anticipated","url":"https://stock-news.laohu8.com/highlight/detail?id=2653719702","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653719702?lang=en_us&edition=fundamental","pubTime":"2026-07-21 19:05","pubTimestamp":1784631900,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260721:nTUA9N8JS8:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AKTX","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653719052","title":"Akari Therapeutics - Co and Whitehawk to Conduct Preclinical Studies of Ph1 Payload with Top1i ADC Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2653719052","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653719052?lang=en_us&edition=fundamental","pubTime":"2026-07-21 19:05","pubTimestamp":1784631900,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260721:nTUA9N8JS8:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AKTX","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653271906","title":"Akari Therapeutics Enters Strategic Research Collaboration with Whitehawk Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2653271906","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653271906?lang=en_us&edition=fundamental","pubTime":"2026-07-21 19:05","pubTimestamp":1784631900,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260721:nTUA9N8JS8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AKTX","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652767214","title":"European Equities Traded in the US as American Depositary Receipts Track Lower in Monday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2652767214","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652767214?lang=en_us&edition=fundamental","pubTime":"2026-07-20 23:13","pubTimestamp":1784560380,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts started the week lower late Monday morning, falling 0.61% to 1,891.41 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by biopharmaceutical company Grifols  and semiconductor company Sequans Communications , which rose 3% and 2.4% respectively. They were followed by medical device maker EDAP TMS  and brewing company Anheuser-Busch InBev , which were up 1.1% and 1% respectively.The decliners from continental Europe were led by biopharmaceutical company DBV Technologies  and software company SAP , which fell 3.7% and 2.6% respectively. They were followed by pharmaceutical company Sanofi  and internet ad firm Criteo , which were down 1.8% and 1.3% respectively.The gainers from the UK were led by biopharmaceutical company Akari Therapeutics  and alcoholic beverage company Diageo , which increased 5.2% and 0.8% respectively. They were followed by insurance company Prudential  and communication","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4117","SQNS","BUD","TRIB","IE00BFMHRM44.USD","AFG","BK4139","CRTO","DAVA.AU","IEUR","BK4134","BK4588","DEO","SNY","BK4528","IE00BFXG1179.USD","BK4007","DBVT","BUD.AU","FOCL","BK7119","AKTX","BK4585","BK4141","BK4613","SAP","BK4169","WPP","BK4009","NCNA","BDRX","BK4082","DAVA","LU0084288595.USD","WPP.AU","DGE.UK","EPV","GRFS","LU0648005311.SGD","BK4559","BK4158","BK4162","PUK","BK4023","BK4107"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652215713","title":"Maxim upgrades Akari Therapeutics to Buy on AKTX-101 data, ADC M&A","url":"https://stock-news.laohu8.com/highlight/detail?id=2652215713","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652215713?lang=en_us&edition=fundamental","pubTime":"2026-07-20 20:55","pubTimestamp":1784552128,"startTime":"0","endTime":"0","summary":"As previously reported, Maxim upgraded Akari Therapeutics (AKTX) to Buy from Hold with a $30 price target. The firm attributes the upgrade to a com...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/maxim-upgrades-akari-therapeutics-to-buy-on-aktx-101-data-adc-ma-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/maxim-upgrades-akari-therapeutics-to-buy-on-aktx-101-data-adc-ma-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AKTX","ADC","PEVC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652621893","title":"Akari Therapeutics Plc : Maxim Group Raises to Buy from Hold","url":"https://stock-news.laohu8.com/highlight/detail?id=2652621893","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652621893?lang=en_us&edition=fundamental","pubTime":"2026-07-20 19:48","pubTimestamp":1784548103,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260720:nFWN43M0R8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","AKTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649992507","title":"European Equities Traded in the US as American Depositary Receipts Decline Sharply in Wednesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2649992507","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649992507?lang=en_us&edition=fundamental","pubTime":"2026-07-08 23:09","pubTimestamp":1783523397,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were tracking lower late Wednesday morning, falling 1.11% to 1,892.74 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by petroleum refiner Equinor  and oil and gas company Eni , which rose 2.4% each. They were followed by accommodations booking site trivago  and pharmaceutical company Ascendis Pharma , which gained 1.7% and 0.7%, respectively.The decliners from continental Europe were led by lender Banco Santander  and software company SAP , which fell 5.1% and 3.7%, respectively. They were followed by internet advertising company Criteo  and biopharmaceutical company Cellectis , which declined 3.5% and 1.1%, respectively.The gainers from the UK were led by oil and gas company BP  and biotech company Autolus Therapeutics , which advanced 1.7% and 1.6%, respectively. They were followed by telecommunications company Vodafone Group  and educational publisher Pearson , which each gained 0.5%","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AKTX","BK4009","USE","CLLS","PSO","WTIU","BK4107","WPP.AU","LU0162691827.USD","BK4521","DRLL","BPH","DBE","PXE","IEO","VOD","PXJ","BK4139","AFG","VDE","IEUR","BK4204","SAN.AU","LU0006061336.USD","BK4111","CRTO","DIG","GUSH","WPP","TRIB","TRVG","EPV","AUTL","DBC","EQNR","ERX","BK4201","IXC","BK4585","SAN","FTXN","BP","XES","ASND","MEDI","E","SLN","SAP","GSIB","DRIP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649346529","title":"Akari Therapeutics (AKTX) Stock Rallies on a Scientific Advisory Board Addition","url":"https://stock-news.laohu8.com/highlight/detail?id=2649346529","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649346529?lang=en_us&edition=fundamental","pubTime":"2026-07-08 01:34","pubTimestamp":1783445653,"startTime":"0","endTime":"0","summary":"Akari Therapeutics stock rallied on Tuesday after the company added Patricia LoRusso to its Scientific Advisory Board.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/akari-therapeutics-aktx-stock-rallies-on-a-scientific-advisory-board-addition?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/akari-therapeutics-aktx-stock-rallies-on-a-scientific-advisory-board-addition?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AKTX","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649980111","title":"Akari Therapeutics Appoints Former Aacr President and Renowned Oncology Drug Development Leader, Patricia Lorusso, D.o., to Scientific Advisory Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2649980111","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649980111?lang=en_us&edition=fundamental","pubTime":"2026-07-07 20:55","pubTimestamp":1783428900,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nTUA2SYCDW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AKTX","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649980120","title":"Press Release: Akari Therapeutics Appoints Former AACR President and Renowned Oncology Drug Development Leader, Patricia Lorusso, D.O., to Scientific Advisory Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2649980120","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649980120?lang=en_us&edition=fundamental","pubTime":"2026-07-07 20:55","pubTimestamp":1783428900,"startTime":"0","endTime":"0","summary":"Globally recognized leader in early-phase oncology clinical development and experimental therapeuticsStrengthens strategic expertise as Akari advances its novel ADC payload that modulates RNA splicing","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AKTX","BK4007","BK4539","BK4139","BK4202","NCI","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649671632","title":"Akari Therapeutics Publishes 2025 Annual Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2649671632","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649671632?lang=en_us&edition=fundamental","pubTime":"2026-07-07 04:39","pubTimestamp":1783370379,"startTime":"0","endTime":"0","summary":"Akari Therapeutics publishes 2025 annual reportAkari Therapeutics published its annual report for the year ended Dec. 31, 2025, pivoting to next-generation antibody-drug conjugates built on proprietar","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260706:nNDLxvNwk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AKTX","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649025620","title":"European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2649025620","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649025620?lang=en_us&edition=fundamental","pubTime":"2026-07-06 23:21","pubTimestamp":1783351284,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were tracking modestly higher late Monday morning, rising 0.33% to 1,919.10 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by telecommunications company Nokia  and semiconductor company Sequans Communications , which rose 5.3% and 5% respectively. They were followed by biotech firm Evaxion  and telecommunications company Ericsson , which were up 3.7% and 2.4% respectively.The decliners from continental Europe were led by biotech firm BioNTech  and pharmaceutical company Novo Nordisk , which fell 3% and 2.8% respectively. They were followed by brewing company Anheuser-Busch InBev  and consumer goods company Unilever , which were down 2.3% and 2.2% respectively.The gainers from the UK were led by biopharmaceutical company NuCana  and communications company WPP , which advanced 4.4% and 2.4% respectively. They were followed by lenders Barclays  and HSBC , which increased 1.5% and 1.4% resp","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AKTX","HSBH","LU2089984988.USD","NOK","PPH","AFG","BK4588","WPP","BCS","HSBC","NCNA","NVOH","AZNH","NVOX","BK4505","AZN","DAVA.AU","LU0029864427.USD","LU0289739699.SGD","LU0006061336.USD","IEUR","EPV","LNOK","BK4591","LU1829250122.USD","NVO.AU","BUD.AU","LU2237443622.USD","ULVR.UK","BK4554","BNTX","IE00BMPRXR70.SGD","UL","SQNS","DAVA","LU0124676726.USD","LU2456880835.USD","UN","LU0689626769.HKD","ERIC","NVO","BUD","OZEM","BK4134","THNR","BK7119","LU2237443978.SGD","WPP.AU","EVAX","MREO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649264252","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2649264252","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649264252?lang=en_us&edition=fundamental","pubTime":"2026-07-06 16:20","pubTimestamp":1783326014,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Akari Therapeutics (AKTX) and Dianthus Therapeutics ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-244?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-244?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBRN","DNTH","BK4139","AKTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648635716","title":"Akari Therapeutics Holds Annual General Meeting, Shareholders Vote on Director Re-elections","url":"https://stock-news.laohu8.com/highlight/detail?id=2648635716","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648635716?lang=en_us&edition=fundamental","pubTime":"2026-07-03 05:26","pubTimestamp":1783027562,"startTime":"0","endTime":"0","summary":"Akari Therapeutics holds annual general meeting, shareholders vote on director re-electionsAkari held its annual general meeting on June 30, 2026.Shareholders adopted the annual report and accounts fo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260702:nNDL8fLSWD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AKTX","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648352026","title":"Akari Therapeutics - Prospectus Relates to Resale of up to 6 Mln Adss Representing 480 Bln Ordinary Shares by the Selling Shareholders - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2648352026","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648352026?lang=en_us&edition=fundamental","pubTime":"2026-07-03 05:22","pubTimestamp":1783027320,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260702:nFWN4340Y0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AKTX","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648268984","title":"European Equities Traded in the US as American Depositary Receipts Rise Sharply in Thursday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2648268984","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648268984?lang=en_us&edition=fundamental","pubTime":"2026-07-02 23:13","pubTimestamp":1783005214,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were sharply higher late Thursday morning, advancing 2.21% to 1,927.62 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by biopharmaceutical company Cellectis  and biotech firm Evaxion , which climbed 14% and 6.9% respectively. They were followed by biotech company BioNTech  and biopharmaceutical company DBV Technologies , which advanced 4.5% and 4.1% respectively.The only decliners from continental Europe were telecommunications company Nokia  and medical device maker EDAP , which were down 1% and 0.8% respectively.The gainers from the UK were led by biopharmaceutical companies Akari Therapeutics  and NuCana , which rose 8.6% and 6.6% respectively. They were followed by biotech firm Autolus Therapeutics  and pharmaceutical company Silence Therapeutics , which were up 4.8% and 3.7% respectively.The only decliners from the UK and Ireland were biopharmaceutical companies Biodexa Pharmaceuti","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4535","SLN","FOCL","BK4568","BK4007","AFG","CLLS","AUTL","NCNA","BK4588","BK4020","BK4117","BK4551","BK4107","EVAX","IEUR","AKTX","LNOK","BK4547","BDRX","IE00BMPRXN33.USD","BK4082","EPV","LU0006061336.USD","NOK","BK4548","BK4139","BK4585","AMRN","BNTX","DBVT","IE00BMPRXR70.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647728308","title":"European Equities Traded in the US as American Depositary Receipts Track Higher in Monday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2647728308","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647728308?lang=en_us&edition=fundamental","pubTime":"2026-06-29 23:11","pubTimestamp":1782745882,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were trending higher late Monday morning, rising 0.60% to 1,888.94 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by biopharmaceutical companies Cellectis  and DBV Technologies , which advanced 6% and 2.7% respectively. Also rising were internet advertising firm Criteo  and biotech company Evaxion , which increased 3.6% and 6.3% respectively.The decliners from continental Europe were led by telecommunications operator Nokia  and medical device maker EDAP TMS , which fell 2.8% and 1% respectively.  Anheuser-Busch InBev, which was off 1.2%.The gainers from the UK were led by biopharmaceutical company NuCana  and software firm Endava , which rose 3.2% and 2.5% respectively. They were followed by biopharmaceutical company Mereo BioPharma Group  and oil and gas company BP , which were up 1.4% and 1.1% respectively.The decliners from the UK and Ireland were led by biopharmaceutical companies ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","BP","BK4585","DBVT","BDRX","BK4588","DAVA.AU","IE00BMPRXR70.SGD","CRTO","DAVA","BK4020","LU1829250122.USD","LU0300736062.USD","LU0072461881.USD","BK4134","FOCL","BK4107","LU0648005311.SGD","BK4082","BK4547","BK4117","AFG","BK4201","AKTX","BUD","EVAX","IE00BFMHRM44.USD","BK4158","LU0084288595.USD","LU0162691827.USD","BK4007","IE00BMPRXN33.USD","LU0320765646.SGD","IEUR","LU0300736492.USD","TRIB","BUD.AU","BK4505","AMRN","BK4009","LU0006061336.USD","LU1162221912.USD","BPH","NCNA","CLLS","NOK","BK7119","MREO","EPV","LNOK"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.akaritx.com","stockEarnings":[{"period":"1week","weight":-0.2098},{"period":"1month","weight":-0.1911},{"period":"3month","weight":0.5},{"period":"6month","weight":-0.205},{"period":"1year","weight":-0.8023},{"period":"ytd","weight":-0.2474}],"compareEarnings":[{"period":"1week","weight":-0.0059},{"period":"1month","weight":0.0078},{"period":"3month","weight":0.035},{"period":"6month","weight":0.0721},{"period":"1year","weight":0.1647},{"period":"ytd","weight":0.0836}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Akari Therapeutics, Plc, a clinical-stage biopharmaceutical company, focuses on developing advanced therapies for autoimmune and inflammatory diseases. Its lead product candidate is nomacopan, a second-generation complement inhibitor that prevents inflammatory and prothrombotic activities. The company also develops PASylated-nomacopan, which is in preclinical development for the treatment of geographic atrophy secondary to dry age-related macular degeneration; and hematopoietic stem cell transplant-related thrombotic microangiopathy (HSCT-TMA) combined with nomacopan, which is in phase 3 clinical development for the treatment of pediatric HSCT-TMA. The company is headquartered in Boston, Massachusetts.","yearOnYearQuotes":[{"month":1,"riseRate":0.416667,"avgChangeRate":0.007289},{"month":2,"riseRate":0.25,"avgChangeRate":-0.164819},{"month":3,"riseRate":0.384615,"avgChangeRate":0.051328},{"month":4,"riseRate":0.461538,"avgChangeRate":0.052868},{"month":5,"riseRate":0.230769,"avgChangeRate":0.014482},{"month":6,"riseRate":0.461538,"avgChangeRate":0.016983},{"month":7,"riseRate":0.307692,"avgChangeRate":0.010675},{"month":8,"riseRate":0.5,"avgChangeRate":0.23135},{"month":9,"riseRate":0.5,"avgChangeRate":0.047326},{"month":10,"riseRate":0.25,"avgChangeRate":-0.130903},{"month":11,"riseRate":0.416667,"avgChangeRate":-0.07207},{"month":12,"riseRate":0.25,"avgChangeRate":-0.096768}],"exchange":"NASDAQ","name":"Akari Therapeutics PLC","nameEN":"Akari Therapeutics PLC","securityTypeName":"DR","adrRate":"1:2000"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Akari Therapeutics PLC(AKTX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Akari Therapeutics PLC(AKTX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Akari Therapeutics PLC,AKTX,Akari Therapeutics PLC股票,Akari Therapeutics PLC股票老虎,Akari Therapeutics PLC股票老虎国际,Akari Therapeutics PLC行情,Akari Therapeutics PLC股票行情,Akari Therapeutics PLC股价,Akari Therapeutics PLC股市,Akari Therapeutics PLC股票价格,Akari Therapeutics PLC股票交易,Akari Therapeutics PLC股票购买,Akari Therapeutics PLC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Akari Therapeutics PLC(AKTX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Akari Therapeutics PLC(AKTX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction